Quick View
| Metric | Current Period | Year-Ago Period | YoY |
|---|---|---|---|
| Revenue | ¥19194.9B | ¥19239.0B | −0.2% |
| Operating Income | ¥710.4B | ¥1038.2B | −31.6% |
| Profit Before Tax | ¥746.6B | ¥1076.5B | −30.6% |
| Net Income | ¥459.5B | ¥823.2B | −44.2% |
| ROE (Annualized) | 3.3% | 6.0% | - |
Executive Summary
The most important point in the current period is that, following a shift from a combination of revenue growth and profit decline, the factors behind the profit decline were concentrated in a cost structure characterized by higher SG&A expenses and impairment losses. Revenue remained broadly flat at ¥19194.9B (YoY -0.2%), while Operating Income declined significantly to ¥710.4B (same period -31.6%), Profit Before Tax, equivalent to Ordinary Income, fell to ¥746.6B (same period -30.6%), and Net Income decreased to ¥459.5B (same period -44.2%). The Operating Margin was 3.7%, down 1.7pt from 5.4% in the year-ago period. This decline was attributable not to deterioration in the cost-of-sales ratio, but primarily to an increase in the SG&A ratio (14.2%→14.6%) and impairment losses of ¥275.5B (up ¥249.3B YoY).
Factors Affecting Results
【Revenue】Revenue was ¥19194.9B, essentially flat at -0.2% year on year. Cost of sales decreased 0.5% year on year to ¥15364.8B, and the gross margin improved slightly to 20.0% from 19.8% in the year-ago period. The scale of the top line itself was maintained, with no sharp change observed on the demand side.
【Profit and Loss】SG&A expenses increased 3.1% year on year to ¥2806.9B, and the SG&A ratio rose from 14.2% to 14.6% despite the decline in revenue. Other expenses reached ¥370.0B, primarily due to impairment losses of ¥275.5B, which increased significantly from ¥26.2B in the year-ago period. Excluding this impairment, the decline in fixed-cost absorption capacity was a backdrop to the decrease in Operating Income. Equity-method investment income of ¥114.6B (up 33.3% year on year) provided partial support, but was insufficient to prevent declines in Operating Income of ¥710.4B (-31.6%) and Net Income of ¥459.5B (-44.2%). In conclusion, the Company is in a phase of profit decline despite no revenue decrease—in substance, a profit decline amid stagnant revenue—rather than a phase of revenue growth accompanied by profit decline.
Key Financial Indicators
【Profitability】The Operating Margin of 3.7% declined 1.7pt from 5.4% in the year-ago period, while the Net Profit Margin decreased to 2.4% (2.1% based on profit attributable to owners of the parent) from 3.9% in the year-ago period. The gross margin improved slightly to 20.0% from 19.8% in the year-ago period, with no deterioration at the cost level.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥764.4B, approximately 1.9 times profit attributable to owners of the parent of ¥401.6B, indicating sound cash backing for earnings. However, trade receivables of ¥730.5B and inventories of ¥133.5B tied up funds, leaving room to improve working capital efficiency.【Investment Efficiency】Annualized ROE was 3.3%, and the EBIT Margin was 3.7%, both remaining at low levels. Capital expenditures of ¥1149.7B exceeded OCF, limiting cash generation after investing activities.【Financial Soundness】The Equity Ratio declined to 50.1% from 51.9% in the year-ago period, but the financial foundation remained generally stable. Bonds and borrowings totaled ¥9421.2B, an increase of ¥1425.7B year on year, indicating a slight increase in reliance on external financing.
Cash Flow Analysis
OCF was ¥764.4B, down 48.1% year on year, affected by a sharp increase in income taxes paid to ¥706.1B from ¥297.3B in the previous year, as well as deterioration in working capital. Investing Cash Flow was -¥623.8B, with capital expenditures of ¥1149.7B representing the largest outflow item. Capital expenditures were not covered by OCF alone, and disclosed free cash flow, including proceeds from the sale of investment securities and other items, remained limited at ¥140.6B. Financing Cash Flow was -¥162.1B, with dividend payments of ¥290.8B and share repurchases of ¥784.4B being the primary outflows, partially offset by an increase in short-term borrowings. Cash and cash equivalents totaled ¥2455.6B, increasing from the previous year, including a foreign exchange translation gain of ¥104.1B. Overall, cash generation from operating activities weakened relative to earnings, and working capital pressures are affecting the capacity for investment and shareholder returns.
Earnings Quality
The decline in earnings during the current period reflects a combination of temporary and recurring factors. Impairment losses of ¥275.5B included in other expenses of ¥370.0B increased sharply by ¥249.3B year on year and represent a temporary factor explaining a substantial portion of the ¥710.4B decline in Operating Income. Meanwhile, the 3.1% year-on-year increase in SG&A expenses represents a recurring cost increase that occurred while revenue remained broadly flat, indicating a structural decline in fixed-cost absorption capacity. Equity-method investment income of ¥114.6B (up 33.3% year on year) boosted earnings as a non-operating supporting factor. OCF was ¥764.4B, exceeding profit attributable to owners of the parent of ¥401.6B, indicating sound cash backing for earnings from an accrual perspective; however, increases in trade receivables and inventories have partially weakened quality from a working capital perspective.
Earnings Forecast and Guidance
The Company’s full-year forecast is revenue of ¥26000B, EPS of ¥54.43, and a dividend of ¥20.00. Q3 cumulative revenue of ¥19194.9B represents 73.8% progress against the full-year forecast, broadly in line with a standard pace of progress. Meanwhile, based on the range for which cumulative Net Income attributable to owners of the parent can be confirmed, the Q3 cumulative progress rate remains around 5割, indicating that profit progress is lagging revenue progress. Recovery in the profit margin in Q4 and containment of temporary burdens such as impairment losses will be key to achieving the full-year plan.
Shareholder Returns
The Company’s full-year dividend forecast is ¥20.00 per share, including a Q2 dividend of ¥10.00. Based on the number of shares outstanding, the annual dividend total is approximately ¥300.9B, and the forecast Payout Ratio against the full-year Net Income forecast of ¥820.0B is approximately 36.7%, a level that is not excessive from a sustainability perspective. Meanwhile, the Company conducted share repurchases of ¥784.4B during the current period, bringing total shareholder returns, including dividends and share repurchases, to approximately ¥1085.3B—substantially exceeding Q3 cumulative profit attributable to owners of the parent of ¥401.6B. The Payout Ratio based solely on dividends is within a sound range, but the Total Return Ratio, including share repurchases, exceeds the current period’s free cash flow generation capacity, increasing reliance on cash on hand and proceeds from asset sales as sources of shareholder returns.
Risk Factors
-
Declining profitability: The Operating Margin of 3.7% declined 1.7pt from 5.4% in the year-ago period and was 4.9pt below the industry median of 8.6%. The increase in the SG&A ratio and decline in fixed-cost absorption capacity remain structural challenges.
-
Increase in impairment losses: Impairment losses of ¥275.5B included in other expenses increased significantly from ¥26.2B in the year-ago period. If the recovery of asset earning power is delayed, additional asset valuation risk will remain.
-
Deterioration in working capital: Trade receivables increased ¥898.8B year on year, while inventories increased ¥133.5B, placing pressure on OCF. These increases occurred while revenue remained flat, making the efficiency of collections and inventory management key areas for monitoring going forward.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 3.7% | 8.6% (4.3%–12.7%) | −4.9pt |
| Net Profit Margin | 2.4% | 6.4% (2.8%–10.3%) | −4.0pt |
Both metrics are substantially below the industry median, placing the Company in the lower tier of the industry in terms of profitability.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (Year on Year) | −0.2% | 3.3% (-2.1%–8.9%) | −3.5pt |
Revenue growth also falls below the industry median, confirming the relative stagnation of the top line.
※Source: Compiled by the Company
Key Points from the Earnings Results
-
While revenue remained essentially flat, the Operating Margin declined 170bp. The primary causes of the profit decline were higher SG&A expenses and impairment losses of ¥275.5B, making improvements in the cost structure and fixed-cost absorption capacity key areas of focus going forward.
-
OCF reached approximately 1.9 times profit attributable to owners of the parent, indicating sound cash backing for earnings; however, increases in trade receivables and inventories are placing pressure on working capital. Trends in collection and inventory efficiency are structural issues that will affect future cash flow.
-
The Payout Ratio is approximately 36.7%, within a sustainable range; however, total shareholder returns, including share repurchases of ¥784.4B, exceed the current period’s earnings and free cash flow generation capacity, requiring attention to the composition of the funding sources for shareholder returns.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (bearish) | ¥1,010 |
| base (base case) | ¥1,024 |
| bull (bullish) | ¥1,037 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥1,187 |
| Adjusted Forecast EPS | ¥50.5 |
| Cost of Equity r | 9.27% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 36.7% |
| Forecast EPS Confidence Adjustment | ×0.928 (based on the Company’s historical track record of achieving guidance) |
| implied PBR / PER | 0.86x / 20.3x |
Sensitivity: ¥995–¥1,053 at a ±1% change in the cost of equity, and ¥1,018–¥1,027 at a change of ±0.1 in ω.
Notes:
- As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee the future share price.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting experts as necessary.
---End of Report---